On Mar. 17, 2020, BioMedomics announced it will be able to distribute their COVID-19 IgM-IgG Antibody Rapid Test to any licensed healthcare practitioner in the U.S. for diagnostic use starting Mar. 17, 2020. Distribution is provided by the FDA updated ﾓPolicy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency.ﾔ